Insights from 2023 SABCS
Playback speed
10 seconds
SABCS 2023 Insights: "APHINITY Trial - The Benefit of Adjuvant Pertuzumab & Trastuzumab According to Estrogen Receptor and HER2 Expression"
By
Insights from 2023 SABCS
FEATURING
Elisa Agostinetto
By
Insights from 2023 SABCS
FEATURING
Elisa Agostinetto
275 views
December 13, 2023
Login to view comments.
Click here to Login
Videos